Canine Arthritis Treatment Market Forecasted to Reach USD $3.12 Billion by 2030 at 4.7% CAGR
The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.
What Are the Projections for Canine Arthritis Treatment Market Size and CAGR During 2026-2030?
The canine arthritis treatment market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to growing prevalence of canine arthritis, rising awareness among pet owners, advancements in veterinary pharmaceuticals, increase in dog population, expansion of veterinary clinics and hospitals.
The canine arthritis treatment market size is expected to see steady growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted biologic therapies, increasing adoption of precision medicine in veterinary care, innovation in surgical techniques for joint repair, growth of online and retail veterinary pharmacies, rising investment in stem cell and prp research. Major trends in the forecast period include rising adoption of non-steroidal anti-inflammatory drugs (nsaids), increased use of joint supplements like glucosamine and chondroitin, growth in stem cell therapy and platelet-rich plasma (prp) treatments, expansion of minimally invasive surgical procedures for dogs, integration of physical therapy and cold laser therapy in arthritis management.
Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp
What Are the Primary Growth Contributors in the Canine Arthritis Treatment Market?
The rising pet ownership rate is expected to propel the growth of the canine arthritis treatment market going forward. Pet ownership refers to the responsibility and care taken by individuals or households in providing for the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. The rising pet ownership rates are due to factors such as lifestyle changes, the humanization of pets, and higher disposable incomes. Pet owners use canine arthritis treatments to manage and alleviate the symptoms of arthritis in their dogs, aiming to improve their pets' quality of life and maintain mobility. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the rising pet ownership rate is driving the growth of the canine arthritis treatment market.
What Are the Main Segments of the Canine Arthritis Treatment Market?
The canine arthritis treatment market covered in this report is segmented –
1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture
What Are the Future Trends Forecasted for the Canine Arthritis Treatment Market?
Major companies operating in the canine arthritis treatment market are developing innovative treatments, such as bedinvetmab injections, to address canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection that works by targeting and neutralizing nerve growth factor (NGF), a protein involved in pain used in veterinary medicine. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. It is the first monoclonal antibody (mAb) approved by the FDA for use in dogs and works by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which is involved in the regulation of pain associated with OA. It is administered by subcutaneous injection once a month, making it a convenient and long-term solution for canine OA pain management.
Who Are the Leading Companies in the Canine Arthritis Treatment Industry by Revenue?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.
Get the full canine arthritis treatment market report here:
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report
Which region represents the fastest-growing market for the Canine Arthritis Treatment Market?
North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment